Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action
Open Access
- 28 August 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 12 (04) , 487-499
Abstract
Several studies have demonstrated that systemically administered N-methyl-d-aspartate (NMDA) receptor antagonists increase serotonin (5-HT) and glutamKeywords
This publication has 73 references indexed in Scilit:
- NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal NeuronsThe Journal of Neuroscience, 2007
- Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidineProceedings of the National Academy of Sciences, 2007
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Fine-Tuning of Awake Prefrontal Cortex Neurons by Clozapine: Comparison With Haloperidol and N-DesmethylclozapineBiological Psychiatry, 2007
- Disruption of Prepulse Inhibition after Stimulation of Central but not Peripheral α-1 Adrenergic ReceptorsNeuropsychopharmacology, 2006
- The principal features and mechanisms of dopamine modulation in the prefrontal cortexProgress in Neurobiology, 2004
- What's atypical about atypical antipsychotic drugs?Current Opinion in Pharmacology, 2004
- Stimulation of α1‐adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5‐hydroxytryptamine release: reversal by antipsychotic drugsJournal of Neurochemistry, 2003
- Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortexSynapse, 1995
- Electrophysiological evidence for a functional interaction between 5‐HT1A and 5‐HT2A receptors in the rat medial prefrontal cortex: An lontophoretic studySynapse, 1994